{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:00Z","timestamp":1791907200523,"version":"4.3.4"},"reference-count":70,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":96,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001784","name":"Victoria University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008409","name":"Ministerio de Fomento","doi-asserted-by":"publisher","award":["2020\u03a3\u039501300001"],"award-info":[{"award-number":["2020\u03a3\u039501300001"]}],"id":[{"id":"10.13039\/501100008409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.csbj.2022.04.010","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T11:17:53Z","timestamp":1649503073000},"page":"2091-2111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2"],"prefix":"10.34133","volume":"20","author":[{"given":"Harry","family":"Ridgway","sequence":"first","affiliation":[{"name":"Institute for Sustainable Industries and Liveable Cities, Victoria University, Melbourne, Australia"},{"name":"AquaMem Consultants, Rodeo, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham J.","family":"Moore","sequence":"additional","affiliation":[{"name":"Pepmetics Inc., 772 Murphy Place, Victoria, BC V6Y 3H4, Canada"},{"name":"Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mavromoustakos","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National Kapodistrian University of Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsiodras","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ligielli","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National Kapodistrian University of Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kelaidonis","sequence":"additional","affiliation":[{"name":"NewDrug PC, Patras Science Park, Patras, 26504, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos T.","family":"Chasapis","sequence":"additional","affiliation":[{"name":"NMR Facility, Instrumental Analysis Laboratory, School of Natural Sciences, University of Patras, Patras, Greece"},{"name":"Institute of Chemical Engineering Sciences, Foundation for Research and Technology, Hellas (FORTH\/ICE-HT), Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Kate","family":"Gadanec","sequence":"additional","affiliation":[{"name":"Institute for Health and Sport, Victoria University, Melbourne, VIC 3030 Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Zulli","sequence":"additional","affiliation":[{"name":"Institute for Health and Sport, Victoria University, Melbourne, VIC 3030 Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasso","family":"Apostolopoulos","sequence":"additional","affiliation":[{"name":"Institute for Health and Sport, Victoria University, Melbourne, VIC 3030 Victoria, Australia"},{"name":"Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, VIC Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Petty","sequence":"additional","affiliation":[{"name":"Ninewells Hospital and Medical School, University of Dundee, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Karakasiliotis","sequence":"additional","affiliation":[{"name":"Laboratory of Biology, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis G.","family":"Gorgoulis","sequence":"additional","affiliation":[{"name":"Ninewells Hospital and Medical School, University of Dundee, Dundee, UK"},{"name":"Department of Histology and Embryology, Faculty of Medicine, National Kapodistrian University of Athens, GR-11527 Athens, Greece"},{"name":"Faculty Institute for Cancer Sciences, Manchester Academic Health Sciences Centre, University of Manchester, M20 4GJ Manchester, UK"},{"name":"Biomedical Research Foundation, Academy of Athens, GR-11527 Athens, Greece"},{"name":"Faculty of Health and Medical Sciences, University of Surrey, GU2 7XH Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Matsoukas","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Alberta T2N 4N1, Canada"},{"name":"NewDrug PC, Patras Science Park, Patras, 26504, Greece"},{"name":"Institute for Health and Sport, Victoria University, Melbourne, VIC 3030 Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"e_1_3_5_2_2","article-title":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection","volume":"9","author":"Guo J.","year":"2020","unstructured":"Guo J., Huang Z., Lin L. and Lv J.: Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc 2020; 9.","journal-title":"J Am Heart Assoc"},{"key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/221337a0","article-title":"Role of a buried acid group in the mechanism of action of chymotrypsin","volume":"221","author":"Blow D.M.","year":"1969","unstructured":"Blow D.M., Birktoft J.J. and Hartley B.S.: Role of a buried acid group in the mechanism of action of chymotrypsin. Nature 1969; 221: 337.","journal-title":"Nature"},{"key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejmech.2012.12.044","article-title":"Rational design, efficient syntheses and biological evaluation of N, N \u2032-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers","volume":"62","author":"Agelis G.","year":"2013","unstructured":"Agelis G. et al: Rational design, efficient syntheses and biological evaluation of N, N \u2032-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. Eur J Med Chem 2013; 62: 352.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01116558"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(89)80157-3"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","unstructured":"Fatouros PR Roy U Sur S. Modeling substrate coordination to Zn-bound angiotensin converting enzyme 2. bioRxiv preprint (2021).","DOI":"10.1101\/2021.03.27.437352"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1021\/ml400489b","article-title":"Predicting the reactivity of nitrile-carrying compounds with cysteine: A combined computational and experimental study","volume":"5","author":"Berteotti A.","year":"2014","unstructured":"Berteotti A. et al: Predicting the reactivity of nitrile-carrying compounds with cysteine: A combined computational and experimental study. ACS Med Chem Lett 2014; 5: 501.","journal-title":"ACS Med Chem Lett"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179124"},{"key":"e_1_3_5_10_2","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.692168","article-title":"Catalytic dyad residues His41 and Cys145 Impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease","volume":"9","author":"Ferreira J.C.","year":"2021","unstructured":"Ferreira J.C., Fadl S., Villanueva A.J. and Rabeh W.M.: Catalytic dyad residues His41 and Cys145 Impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease. Front Chem 2021; 9.","journal-title":"Front Chem"},{"key":"e_1_3_5_11_2","article-title":"An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19","author":"Owen D.R.","year":"2021","unstructured":"Owen D.R. et al: An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19. Science 2021; .","journal-title":"Science"},{"key":"e_1_3_5_12_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0306-3623(89)90015-3","article-title":"Methods for analyzing and interpreting cooperativity in dose-response curves\u2014II. Partial agonists acting on muscarinic receptors in smooth muscle","volume":"20","author":"Moore G.J.","year":"1989","unstructured":"Moore G.J.: Methods for analyzing and interpreting cooperativity in dose-response curves\u2014II. Partial agonists acting on muscarinic receptors in smooth muscle. Gen Pharmacol Vasc Syst 1989; 20: 199.","journal-title":"Gen Pharmacol Vasc Syst"},{"key":"e_1_3_5_13_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0306-3623(90)90596-E","article-title":"The relationship between homotropic and heterotropic cooperativity for angiotensin receptors in smooth muscle","volume":"21","author":"Scanlon M.N.","year":"1990","unstructured":"Scanlon M.N., Koziarz P. and Moore G.J.: The relationship between homotropic and heterotropic cooperativity for angiotensin receptors in smooth muscle. General Pharmacology: The Vascular System 1990; 21: 59.","journal-title":"General Pharmacology: The Vascular System"},{"key":"e_1_3_5_14_2","first-page":"91","article-title":"Design and pharmacology of peptide mimetics","volume":"33","author":"Moore G.J.","year":"1995","unstructured":"Moore G.J., Smitht J.R., Baylis B.W. and Matsoukas J.M.: Design and pharmacology of peptide mimetics. Proc West Pharmacol Soc 1995; 33: 91.","journal-title":"Proc West Pharmacol Soc"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/0006-291X(90)90782-I","article-title":"Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: Relationship to biological activity and 1H-NMR data","volume":"171","author":"Turner R.J.","year":"1990","unstructured":"Turner R.J., Matsoukas J.M. and Moore G.J.: Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: Relationship to biological activity and 1H-NMR data. Biochem Biophys Res Commun 1990; 171: 996.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_5_16_2","article-title":"Pulmonary edema in COVID-19 patients: mechanisms and treatment potential","volume":"12","author":"Cui X.","year":"2021","unstructured":"Cui X. et al: Pulmonary edema in COVID-19 patients: mechanisms and treatment potential. Front Pharmacol 2021; 12.","journal-title":"Front Pharmacol"},{"key":"e_1_3_5_17_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100962","article-title":"Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial","volume":"37","author":"Duarte M.","year":"2021","unstructured":"Duarte M. et al: Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial. EClinicalMedicine 2021; 37: 100962.","journal-title":"EClinicalMedicine"},{"key":"e_1_3_5_18_2","first-page":"41","article-title":"Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers","volume":"25","author":"Kakuta H.","year":"2005","unstructured":"Kakuta H., Sudoh K., Sasamata M. and Yamagishi S.: Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers. Int J Clin Pharmacol Res 2005; 25: 41.","journal-title":"Int J Clin Pharmacol Res"},{"key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"L1020","DOI":"10.1152\/ajplung.00097.2020","article-title":"Covid-19 infection and mortality: a physiologist\u2019s perspective enlightening clinical features and plausible interventional strategies","volume":"318","author":"Abassi Z.A.","year":"2020","unstructured":"Abassi Z.A., Skorecki K., Heyman S.N., Kinaneh S. and Armaly Z.: Covid-19 infection and mortality: a physiologist\u2019s perspective enlightening clinical features and plausible interventional strategies. Am J Physiol-Lung Cell Mol Physiol 2020; 318: L1020.","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"e_1_3_5_20_2","doi-asserted-by":"crossref","first-page":"L1029","DOI":"10.1152\/ajplung.00133.2020","article-title":"Reply to Letter to the Editor: \u201cDon\u2019t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19\u201d","volume":"318","author":"Abassi Z.A.","year":"2020","unstructured":"Abassi Z.A., Skorecki K., Heyman S.N., Kinaneh S. and Armaly Z.: Reply to Letter to the Editor: \u201cDon\u2019t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19\u201d. Am J Physiol-Lung Cell Mol Physiol 2020; 318: L1029.","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040644"},{"key":"e_1_3_5_22_2","article-title":"Outcomes in patients with COVID-19 infection taking ACEI\/ARB","volume":"22","author":"Rico-Mesa J.S.","year":"2020","unstructured":"Rico-Mesa J.S., White A. and Anderson A.S.: Outcomes in patients with COVID-19 infection taking ACEI\/ARB. Curr Cardiol Reports 2020; 22.","journal-title":"Curr Cardiol Reports"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijid.2020.05.002","article-title":"Urgent need for evaluating agonists of angiotensin-(1\u20137)\/Mas receptor axis for treating patients with COVID-19","volume":"96","author":"Shete A.","year":"2020","unstructured":"Shete A.: Urgent need for evaluating agonists of angiotensin-(1\u20137)\/Mas receptor axis for treating patients with COVID-19. Int J Infect Dis 2020; 96: 348.","journal-title":"Int J Infect Dis"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng J.","year":"2020","unstructured":"Meng J. et al: Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 2020; 9: 757.","journal-title":"Emerg Microbes Infect"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009875117"},{"key":"e_1_3_5_26_2","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1042\/CS20201268","article-title":"ACE2: from protection of liver disease to propagation of COVID-19","volume":"134","author":"Warner Fiona J.","year":"2020","unstructured":"Warner Fiona J., Rajapaksha H., Shackel N. and Herath C.B.: ACE2: from protection of liver disease to propagation of COVID-19. Clin Sci 2020; 134: 3137.","journal-title":"Clin Sci"},{"key":"e_1_3_5_27_2","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni W.","year":"2020","unstructured":"Ni W. et al: Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 2020; 24.","journal-title":"Crit Care"},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang P.","year":"2020","unstructured":"Zhang P. et al: Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 2020; 126: 1671.","journal-title":"Circ Res"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2005760"},{"key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/biom11070979","article-title":"Receptor interactions of angiotensin II and angiotensin receptor blockers\u2014relevance to COVID-19","volume":"11","author":"Moore G.J.","year":"2021","unstructured":"Moore G.J. et al: Receptor interactions of angiotensin II and angiotensin receptor blockers\u2014relevance to COVID-19. Biomolecules 2021; 11: 979.","journal-title":"Biomolecules"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.12.006"},{"key":"e_1_3_5_32_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1139\/o90-028","article-title":"Inhibition of enzymatic degradation of angiotensin II in membrane binding assays: utility of 1,10-phenanthroline","volume":"68","author":"Koziarz P.","year":"1990","unstructured":"Koziarz P. and Moore G.J.: Inhibition of enzymatic degradation of angiotensin II in membrane binding assays: utility of 1,10-phenanthroline. Biochem Cell Biol 1990; 68: 218.","journal-title":"Biochem Cell Biol"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2180-5"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpclett.1c01064"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2013.03.009"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071542"},{"key":"e_1_3_5_37_2","doi-asserted-by":"crossref","unstructured":"Liu Y et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. bioRxiv preprint (2021).","DOI":"10.1101\/2021.08.12.456173"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi7994"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjsbx.2020.100038"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-00908-w"},{"key":"e_1_3_5_41_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0196-9781(90)90093-K","article-title":"1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): Clustering of the aromatic rings in dimethylsulfoxide","volume":"11","author":"Matsoukas J.M.","year":"1990","unstructured":"Matsoukas J.M., Bigam G., Zhou N. and Moore G.J.I.: 1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): Clustering of the aromatic rings in dimethylsulfoxide. Peptides 1990; 11: 359.","journal-title":"Peptides"},{"key":"e_1_3_5_42_2","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1016\/S0021-9258(17)37688-3","article-title":"Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II","volume":"269","author":"Matsoukas J.M.","year":"1994","unstructured":"Matsoukas J.M. et al: Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II. J Biol Chem 1994; 269: 5303.","journal-title":"J Biol Chem"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.689000"},{"key":"e_1_3_5_44_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.phrs.2017.06.013","article-title":"Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism","volume":"123","author":"Takezako T.","year":"2017","unstructured":"Takezako T., Unal H., Karnik S.S. and Node K.: Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism. Pharmacol Res 2017; 123: 40.","journal-title":"Pharmacol Res"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.04.011"},{"key":"e_1_3_5_46_2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/cb500063y","article-title":"Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II","volume":"9","author":"Magnani F.","year":"2014","unstructured":"Magnani F. et al: Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II. ACS Chem Biol 2014; 9: 1420.","journal-title":"ACS Chem Biol"},{"key":"e_1_3_5_47_2","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/ja000092s","article-title":"New strategies for organic catalysis: the first highly enantioselective organocatalytic Diels\u2212Alder reaction","volume":"122","author":"Ahrendt K.A.","year":"2000","unstructured":"Ahrendt K.A., Borths C.J. and MacMillan D.W.C.: New strategies for organic catalysis: the first highly enantioselective organocatalytic Diels\u2212Alder reaction. J Am Chem Soc 2000; 122: 4243.","journal-title":"J Am Chem Soc"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja994280y"},{"key":"e_1_3_5_49_2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/ja0174231","article-title":"The proline-catalyzed direct asymmetric three-component Mannich reaction: scope, optimization, and application to the highly enantioselective synthesis of 1,2-amino alcohols","volume":"124","author":"List B.","year":"2002","unstructured":"List B., Pojarliev P., Biller W.T. and Martin H.J.: The proline-catalyzed direct asymmetric three-component Mannich reaction: scope, optimization, and application to the highly enantioselective synthesis of 1,2-amino alcohols. J Am Chem Soc 2002; 124: 827.","journal-title":"J Am Chem Soc"},{"key":"e_1_3_5_50_2","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1039\/c2cc17203h","article-title":"The crystal structure of l-arginine","volume":"48","author":"Courvoisier E.","year":"2012","unstructured":"Courvoisier E., Williams P.A., Lim G.K., Hughes C.E. and Harris K.D.M.: The crystal structure of l-arginine. Chem Commun 2012; 48: 2761.","journal-title":"Chem Commun"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20084"},{"key":"e_1_3_5_52_2","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","author":"Trott O.","year":"2009","unstructured":"Trott O. and Olson A.J.: AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2009; .","journal-title":"J Comput Chem"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.10349"},{"key":"e_1_3_5_54_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.10104","article-title":"Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field","volume":"47","author":"Krieger E.","year":"2002","unstructured":"Krieger E., Koraimann G. and Vriend G.: Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field. Proteins Struct Funct Bioinf 2002; 47: 393.","journal-title":"Proteins Struct Funct Bioinf"},{"key":"e_1_3_5_55_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09654-8","article-title":"Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology","volume":"7","author":"Bertoni M.","year":"2017","unstructured":"Bertoni M., Kiefer F., Biasini M., Bordoli L. and Schwede T.: Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology. Sci Rep 2017; 7.","journal-title":"Sci Rep"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu426"},{"key":"e_1_3_5_57_2","doi-asserted-by":"crossref","unstructured":"Krieger E Dunbrack RL Hooft RWW Krieger B. Assignment of protonation states in proteins and ligands: combining pKa prediction with hydrogen bonding network optimization. 819 405-421 (2012).","DOI":"10.1007\/978-1-61779-465-0_25"},{"key":"e_1_3_5_58_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jmgm.2006.02.009","article-title":"Fast empirical pKa prediction by Ewald summation","volume":"25","author":"Krieger E.","year":"2006","unstructured":"Krieger E., Nielsen J.E., Spronk C.A.E.M. and Vriend G.: Fast empirical pKa prediction by Ewald summation. J Mol Graph Model 2006; 25: 481.","journal-title":"J Mol Graph Model"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.5b00255"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20035"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.10128"},{"key":"e_1_3_5_62_2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak V.","year":"2006","unstructured":"Hornak V., Abel R., Okur A., Strockbine B., Roitberg A. and Simmerling C.: Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins Struct Funct Bioinf 2006; 65: 712.","journal-title":"Proteins Struct Funct Bioinf"},{"key":"e_1_3_5_63_2","doi-asserted-by":"crossref","unstructured":"Essmann U Perera L Berkowitz ML Darden T Lee H Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys 1995; 103:8577-8593.","DOI":"10.1063\/1.470117"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.23899"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008209117"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1021\/jp054994x"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/prot.22414"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1994.1052"},{"key":"e_1_3_5_69_2","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1021\/jm050038s","article-title":"PMF scoring revisited","volume":"49","author":"Muegge I.","year":"2005","unstructured":"Muegge I.: PMF scoring revisited. J Med Chem 2005; 49: 5895.","journal-title":"J Med Chem"},{"key":"e_1_3_5_70_2","doi-asserted-by":"crossref","first-page":"2102951","DOI":"10.1183\/13993003.02951-2021","article-title":"Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis","author":"Evangelou K.","year":"2022","unstructured":"Evangelou K. et al: Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis. Eur Respir J 2022; : 2102951.","journal-title":"Eur Respir J"},{"key":"e_1_3_5_71_2","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.798","article-title":"p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein","volume":"9","author":"Panagiotopoulos A.","year":"2021","unstructured":"Panagiotopoulos A. et al: p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein. Pharmacol Res Perspect 2021; 9.","journal-title":"Pharmacol Res Perspect"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2022.04.010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:59:36Z","timestamp":1779022776000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2022.04.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":70,"alternative-id":["10.1016\/j.csbj.2022.04.010"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2022.04.010","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2022.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}